BIM
PFE icon

Bullseye Investment Management’s Pfizer PFE Stock Holding History

Bullseye Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.4K Buy
+1,178
New +$30.8K 0.01% 185
2022
Q3 		– Sell
-25,594
Closed -$1.34M – 51
2022
Q2 		$1.34M Buy
+25,594
New +$1.3M 1.2% 19
2022
Q1 		– Sell
-3,662
Closed -$216K – 65
2021
Q4 		$216K Buy
+3,662
New +$181K 0.16% 57

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bullseye Investment Management's PFE Position: Q2 2026 in Review

Bullseye Investment Management opened a new position in Pfizer (PFE) in Q2 2026: 1,178 shares worth $28.4K. The stake represents 0.01% of the portfolio and ranks #185 among its holdings. This is a return to the name: Bullseye Investment Management previously reported a position in PFE as recently as Q2 2022.

Bullseye Investment Management first reported a position in PFE in Q4 2021 and has held it in 3 quarters since. The position peaked at $1.34M in Q2 2022. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bullseye Investment Management held 1,178 shares of Pfizer worth $28.4K as of Q2 2026.
  • Pfizer was a new Bullseye Investment Management position in Q2 2026.
  • Pfizer made up 0.01% of Bullseye Investment Management's portfolio in Q2 2026, its #185 holding.
  • Bullseye Investment Management first reported a position in Pfizer in Q4 2021 and has held it in 3 quarters since.
  • Bullseye Investment Management's Pfizer position peaked at $1.34M in Q2 2022.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bullseye Investment Management's 13F filing for Q2 2026, filed 11 Sep 2026.